Thermo Fisher Scientific (TMO) Research & Development (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Research & Development for 18 consecutive years, with $364.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Research & Development rose 3.41% year-over-year to $364.0 million; the trailing twelve-month figure through Jun 2026 stood at $1.4 billion (down 0.85% YoY), and the FY2025 full-year result was $1.4 billion, up 0.5% from the prior year.
• Research & Development climbed to $364.0 million in Q2 2026 per TMO's latest filing, from $336.0 million in the prior quarter.
• Across five years, Research & Development topped out at $391.0 million in Q4 2022 and bottomed at $319.0 million in Q3 2023.
• Historically, Research & Development has averaged $349.7 million across 5 years, with a median of $346.0 million in 2023.
• The sharpest annual moves came in 2023 and 2024: Research & Development dropped 16.37% in 2023, then rose 14.37% in 2024.
• Over 5 years, Research & Development stood at $391.0 million in 2022, then decreased by 16.37% to $327.0 million in 2023, then grew by 14.37% to $374.0 million in 2024, then slipped by 4.81% to $356.0 million in 2025, then rose by 2.25% to $364.0 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $364.0 million, $336.0 million, and $356.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.